|
Vital KSK Holdings is a Japanese pharmaceutical distribution and healthcare services group operating through five business segments. The company manages pharmaceutical wholesale, pharmacy operations, veterinary pharmaceutical distribution, pharmaceutical manufacturing, and care rental and other services. Key subsidiaries include Vital Net, KSK, Fines, Ono, Good Neighbor, Kenkoudou Pharmacy, Tennohoken Pharmacy Center, Agro Japan, Arrow Medical, Medly Pharma, and Tampo. The group serves customers in the healthcare sector, including hospitals, pharmacies, and veterinary clinics, while also providing logistics, insurance agency, real estate management, and consulting services. Summarised from the annual report, fiscal year ended Mar 2026 |
Industry Medical Distribution | Homepage vitalksk.co.jp |
| Sector Healthcare | IR page vitalksk.co.jp | |
|
Tags
pharmaceutical wholesale, pharmacy operations, veterinary pharmaceuticals, pharmaceutical manufacturing, care rental, logistics, insurance agency, real estate management, consulting services, Vital Net, KSK, Fines, Ono, Good Neighbor, Kenkoudou Pharmacy, Tennohoken Pharmacy Center, Agro Japan, Arrow Medical, Medly Pharma, Tampo, Yachiyo Care Support, Medical Management Research Institute, Vital Green, Vital Care, Vital Express, Oshin Trading, Preark, Kyowa Transport
|
Press page vitalksk.co.jp/ir/news |
Metrics
| Valuation | |
|---|---|
| Market cap | ¥ 80.294B |
| Market cap (USD) | $ 501.843M |
| P/E | 26.18 |
| PEG | 1.74 |
| P/BV | 0.69 |
| P/S | 0.13 |
| P/OCF | 37.21 |
| P/FCF | -19.55 |
| Dividend yield | 4.5% |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 6.5% |
| ROI | 6.0% |
| ROIC | 2.1% |
| Profit margin | 1.2% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 15.1% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 24 |
| Quality score | 5.6% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 610.497B | 600.37B | 587.481B | 579.772B | 577.249B | 537.03B | 562.505B | 559.712B | 565.589B | 581.079B | 621.04B | 548.012B | 564.655B | 547.581B |
| Net profit | 7.362B | 7.308B | 5.843B | 4.831B | 4.77B | 1.171B | 4.642B | 5.084B | 4.467B | 4.778B | 6.556B | 4.527B | 4.235B | 3.908B |
| Free cash flow | -435M | -10.587B | 18.472B | -8.841B | 3.347B | -5.234B | -9.834B | 16.089B | 8.55B | -3.793B | -6.579B | — | — | — |
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 1.465K | 1.258K | 1.256K | 894.33 | 735.03 | 789.04 | 1.097K | 1.092K | 1.047K | 1.032K | 887.73 | 915.05 | 778.94 | 872.04 |
| Price performance 12m | 0.16 | 0 | 0.4 | 0.22 | -0.07 | -0.28 | 0 | 0.04 | 0.01 | 0.16 | -0.03 | 0.17 | -0.11 | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (JPY) | 126B | 122B | 122B | 115B | 115B | 239B | 237B | 236B | 234B | 242B |
| ↳ YoY growth | -15.1% | -3.0% | +0.1% | -5.8% | -0.4% | +108.6% | -1.0% | -0.3% | -0.9% | +3.7% |
| ↳ 5y CAGR | -5.0% | +13.7% | +14.2% | +14.1% | +15.2% | +16.2% | ||||
| Other receivables (JPY) | 15.1B | 15.4B | 15.3B | 15.1B | 15.4B | 16.6B | 16.7B | 16.3B | 12B | 12.8B |
| Borrowings, current (JPY) | 3.59B | 1.36B | 1.37B | 1.6B | 6.57B | 1.96B | 1.96B | 1.86B | 1.87B | 1.93B |
| Borrowings, non-current (JPY) | 14.8B | 14.8B | 14.8B | 14.4B | 8.73B | 7.76B | 6.79B | 5.82B | 4.85B | 3.89B |
| Bonds payable (JPY) | 10B | 10B | 10B | 10B | — | — | — | — | — | — |
| Lease liabilities (JPY) | 1.04B | 869M | 1.96B | 1.61B | 1.5B | 2.13B | 1.5B | 1.43B | 979M | 952M |
| Cash and deposits (JPY) | 23B | 28.3B | 43.2B | 33.1B | 29.8B | 27B | 19B | 34.7B | 23.1B | 23B |
| Intangible assets (JPY) | 7.42B | 6.74B | 5.79B | 5.04B | 4.59B | 5.04B | 3.38B | 3.91B | 4.29B | 6.89B |
| Net debt (borrowings + leases - cash) (JPY) | -3.55B | -11.2B | -25.1B | -15.5B | -13B | -15.1B | -8.78B | -25.6B | -15.4B | -16.2B |
| Cash flow detail | ||||||||||
| Operating cash flow (JPY) | 1.12B | 16.8B | 18.2B | -8.32B | -1.39B | 7.49B | -3B | 23.6B | -8.02B | 4.83B |
| Purchases of property, plant and equipment (JPY) | -4.48B | -7.83B | -1.61B | -1.15B | -3.31B | -3.42B | -5.84B | -1.85B | -2.56B | -3.72B |
| Purchases of intangible assets (JPY) | -432M | -408M | -533M | -361M | -533M | -725M | -759M | -3.25B | -1.77B | -1.55B |
| Change in receivables (cash effect) (JPY) | 23.9B | 3.43B | 77M | 7.22B | 494M | -6.04B | 1.07B | 824M | 5.5B | -4.88B |
| Change in inventories (cash effect) (JPY) | 1.2B | -401M | -1.21B | -165M | 1.65B | -2.45B | 942M | -552M | -1.8B | -3M |
| Change in payables (cash effect) (JPY) | -26.4B | 7.16B | 11.7B | -21.3B | -1.63B | 9.62B | -12.1B | 14.5B | -16.9B | 7.24B |
| Dividends paid (cash effect) (JPY) | -1.46B | -1.13B | -1.13B | -1.29B | -1.38B | -651M | -1.37B | -2.37B | -2.18B | -2.81B |
| Share buybacks (cash effect) (JPY) | -135M | 0.00 | 0.00 | -1.5B | 0.00 | -1.56B | -998M | -1.63B | -2.51B | 0.00 |
| Interest paid (cash effect) (JPY) | -45M | -45M | -73M | -66M | -88M | -98M | -96M | -103M | -80M | -68M |
| Income taxes paid (cash effect) (JPY) | -4.85B | -662M | -2.23B | -2.84B | -2.86B | -1.51B | -3.53B | -3.56B | -2.92B | -2.96B |
| Operating cash flow before change in receivables (JPY) | -22.8B | 13.4B | 18.2B | -15.5B | -1.88B | 13.5B | -4.07B | 22.7B | -13.5B | 9.71B |
| Free cash flow (OCF - PPE - intangibles) (JPY) | -3.79B | 8.55B | 16.1B | -9.83B | -5.23B | 3.35B | -9.6B | 18.5B | -12.4B | -435M |
| Income detail | ||||||||||
| Research and development expense (JPY) | — | — | — | — | — | — | — | — | — | 1.28B |
| Total comprehensive income (JPY) | 6.21B | 9.57B | -527M | 3.2B | 7.67B | -1.66B | 2.49B | 9.76B | 5.93B | 14.1B |
| Comprehensive income to owners (JPY) | 6.12B | 9.49B | -615M | 3.1B | 7.55B | -1.77B | 2.39B | 9.66B | 5.84B | 14B |
| Provision for credit losses (JPY) | — | — | — | — | — | -15M | 568M | -336M | 49M | 23M |
| Credit cost ratio (credit losses / average receivables) (%) | — | — | — | — | — | 0.0% | 0.2% | 0.1% | 0.0% | 0.0% |
| Segments | ||||||||||
| Medicine Wholesale · Segment revenue (JPY) | — | — | — | — | — | — | — | — | 575B | 584B |
| ↳ YoY growth | +1.5% | |||||||||
| Medicine Wholesale · Segment operating income (JPY) | — | — | — | — | — | — | — | — | 5.16B | 4.92B |
| Nursing Care Related Rental And Other Business · Segment revenue (JPY) | — | — | — | — | — | — | — | — | 7.32B | 7.87B |
| ↳ YoY growth | +7.5% | |||||||||
| Nursing Care Related Rental And Other Business · Segment operating income (JPY) | — | — | — | — | — | — | — | — | -78M | -102M |
| Pharmaceutical Business · Segment operating income (JPY) | — | — | — | — | — | — | — | — | — | -1.31B |
| Pharmacy Business · Segment revenue (JPY) | — | — | — | — | 16.8B | 18.4B | 18.4B | 19.1B | 19.6B | 20B |
| ↳ YoY growth | +9.7% | -0.2% | +4.1% | +2.3% | +2.1% | |||||
| Pharmacy Business · Segment operating income (JPY) | — | — | — | — | -19M | 205M | 106M | 310M | 251M | 252M |
| Veterinary Drugs Wholesale Business · Segment revenue (JPY) | — | — | — | 9.71B | 9.81B | 10.4B | 10.9B | 11B | 11.6B | 12.6B |
| ↳ YoY growth | +1.0% | +6.0% | +4.6% | +1.4% | +5.4% | +8.6% | ||||
| Veterinary Drugs Wholesale Business · Segment operating income (JPY) | — | — | — | 353M | 401M | 371M | 339M | 350M | 314M | 304M |
| Reported | Jun 30, 2017 | Jun 29, 2018 | Jun 28, 2019 | Jun 28, 2021 | Jun 29, 2022 | Jun 30, 2023 | Jun 30, 2023 | Jun 27, 2024 | Jun 19, 2026 | Jun 19, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpTimely disclosures published on TDnet, newest first, titles as filed in Japanese. The link opens the disclosure on TDnet. Filings with EDINET (periodic reports, extraordinary reports, offerings, holding and buy-back reports), newest first, titles as filed in Japanese. The link opens the filing on EDINET. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Vital KSK Holdings, Inc.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| DISV | 0.03% | 188,400 | $ 1.658M | Nov 12, 2026 |
| DFIS | 0.01% | 66,700 | $ 586.91K | Nov 12, 2026 |
| AVDV | 0.01% | 245,500 | $ 2.207M | Nov 16, 2026 |
| AVSD | 0.01% | 2,400 | $ 21.576K | Nov 16, 2026 |
| AVDS | 0.01% | 5,800 | $ 52.142K | Nov 16, 2026 |
| DXIV | 0.01% | 1,800 | $ 15.839K | Nov 12, 2026 |
| DFSI | 0.00% | 5,500 | $ 48.396K | Nov 12, 2026 |
| DFIC | 0.00% | 43,522 | $ 382.961K | Nov 12, 2026 |
| DFAX | 0.00% | 27,400 | $ 241.099K | Nov 12, 2026 |
| DFAI | 0.00% | 28,400 | $ 249.899K | Nov 12, 2026 |
| AVDE | 0.00% | 67,700 | $ 608.621K | Nov 16, 2026 |

